15 results about "Glass Vial" patented technology

A method for improving the efficiency of a pharmaceutical filling line by running the filling line at an increased throughput rate is disclosed. The method involves using glass vials that have been strengthened and coated to reduce the coefficient of friction of the outer surface of the vials with a pharmaceutical filling line set at a rate greater than or equal to 600 vials per minute and running in an efficiency of at least 70%.In other embodiments of the invention, the pharmaceutical filling line may also be provided with a polymer chemical coating at points of contact with the glass vials, thereby further reducing the friction between the vials and the points of contact and the effects of impact of the vials with contact points of the pharmaceutical filling line.

This invention belongs to the field of veterinary drugs and discloses a method for preparing difloxacin suspension injection, comprising the following steps: Step 1: Difloxacin is added to an aqueous solution containing gluconolactone to prepare a difloxacin solution; Step 2: A crystallization inhibitor is added to the difloxacin solution in Step 1; Step 3: The solution is dispensed into glass vials for injection, sealed, and sterilized with high-temperature steam; Step 4: The sterilized injection solution is immediately subjected to cold water immersion or cooled to room temperature in air for leak testing and crystallization, simultaneously obtaining difloxacin injection solution. Based on previous research results, this invention further proposes that, in the further optimization process, gluconolactone is used as a co-solvent for difloxacin, dissolved by heating, dispensed into injection bottles, sterilized at high temperature, and then recrystallized after cooling to obtain a suspension with small crystal particle size. This process is suitable for large-scale production.

This invention discloses a fully automated sample pretreatment system for liquid addition, extraction, and filtration, belonging to the field of chemical analysis pretreatment technology. Addressing the problems of low efficiency, health risks, and information confusion associated with manual operation in existing technologies, this invention provides a solution, comprising: a first multi-dimensional robotic arm working in conjunction with a first scanning device to automatically scan, open, and add liquid to sample tubes; a second multi-dimensional robotic arm to move the sample rack, after liquid addition, into an ultrasonic water bath for extraction and then remove it; a three-axis moving mechanism integrating a third gripper and a syringe clamping module to complete secondary scanning, opening, aspiration, filter installation, pressure filtration, and the coding, opening, and closing of glass vials; and a controller coordinating the collaborative work of all components. This invention is mainly used for sample pretreatment in chemical analysis laboratories, achieving full automation of the liquid addition, extraction, and filtration process, improving processing efficiency and sample information traceability.

The utility model relates to medical packaging detection equipment technical field discloses a kind of automatic glass medicine bottle lamp inspection machines, in the device, through bevel gear and sprocket, transmission chain cooperation, the power of driving motor is efficiently transmitted to each transmission cylinder, the stable transmission of glass medicine bottle is realized.Detection light source and reflector in detection shell provide good illumination condition for detection, enhance detection effect, ensure that the impurities in the inside of medicine bottle can be accurately detected, the accuracy and reliability of detection are significantly improved, and at the same time, through the design of spacing adjusting assembly, especially the cooperation of upper positioning pin and sliding block, the spacing between transmission cylinders can be flexibly adjusted, so as to adapt to glass medicine bottles of different sizes.This core technology effectively improves the versatility and application range of the equipment, reduces the equipment adjustment time and cost caused by the change of medicine bottle specifications.

This invention belongs to the field of iodine adsorption material technology, and discloses a method for synthesizing and applying a highly efficient iodine adsorption material. The synthesis method includes: S1, adding an organic aldehyde ligand to a container, adding a solvent, and stirring to completely dissolve the aldehyde ligand; S2, slowly adding the above solution dropwise to an organic amine ligand solution to completely mix it with the amine ligand; S3, sealing the above mixed solution and stirring at room temperature until the color deepens; S4, after the reaction is complete, separating the reaction solution into small glass vials, tightening the caps, loosening them by half a turn, and placing them in a protective atmosphere; after several days of gas-liquid diffusion, visible crystals form at the bottom of the glass vials. The synthesized adsorption material has applications in volatile and radioactive iodine. The crystalline adsorption material synthesized by this invention has good stability, high adsorption efficiency for iodine, and a fast adsorption rate, and can be used for nuclear waste treatment and the capture of radioactive iodine.

The present invention relates to a method for the production of a liquid formulation suitable for intravenous administration in a glass vial with a rubber stopper, where the formulation is dexmedetomidine hydrochloride in water for injection (WFI). The method comprises steps of introducing WFI into a preparation vessel, passing an inert gas through the WFI until a dissolved oxygen content of 1 ppm or less is obtained, adding and dissolving a quantity of sodium chloride and dexmedetomidine hydrochloride, filtering the dexmedetomidine hydrochloride solution, and filling one or more glass vials with the liquid dexmedetomidine hydrochloride-in-WFI formulation before closing said vials with a rubber stopper and sealing the vials. The invention also relates to a sterile liquid formulation of dexmedetomidine hydrochloride in WFI, and its applications.

Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.

A protective sleeve apparatus for multiple vial carriage, said apparatus comprising: a pliable enclosure (sleeve), wherein said sleeve is comprised of a first surface, second surface, and at least three side walls adjoining the first surface with the second surface to form the sleeve; at least one aperture disposed on at least one of the first and / or second surface of the sleeve, wherein said aperture is configured for an insertion or removal of the glass vial into the sleeve; and at least one means of interlocking the sleeve with at least a second sleeve, wherein the interlocking component is disposed on at least one of the side walls of either of the two sleeves, whereby the interlocked sleeves enable protective multiple vial carriage.

Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.

This application discloses CQDs@HOF-101 composite microcrystals, their preparation method, and applications, relating to the field of photocatalytic materials technology, aiming to solve the technical problem of low light utilization rate of existing photocatalytic materials. The preparation method of the CQDs@HOF-101 composite microcrystals includes the following steps: HOF-101 small molecule 1,3,6,8-tetra(4-carboxyphenyl)pyrene is uniformly dissolved in a polar aprotic solvent, and then, along with carbon dots, is placed in a glass vial through an organic filter membrane. The vial is then placed in a beaker containing an alcohol solvent. After the alcohol solvent enters the organic solvent and crystals grow, the crystals are centrifuged to obtain a precipitate. The precipitate is then washed to obtain CQDs@HOF-101 crystals.

The invention provides a preparation method of a copper-loaded magnesium vanadate material and a product and application of the copper-loaded magnesium vanadate material. Vanadate, magnesium salt and copper salt are fully mixed according to the stoichiometric molar ratio and ground in mortar, and A is obtained; transferring the obtained mixture into a 10ml glass vial, adding another 2ml open vial containing 1ml of distilled water, keeping the whole container in an oven at 70-80 DEG C, reacting for 24-30 hours, taking out the vial, drying at the same temperature for 8-10 hours, and regrinding to obtain B; and putting the B into a muffle furnace, heating to 400-600 DEG C at a heating rate of 1-2 DEG C / min, and calcining for 2-4 hours to obtain a final product, namely the copper-loaded magnesium vanadate material. Under the condition of 1 A / g current density, the first specific discharge capacity is 268.8 mAh / g, after 100 cycles, the specific discharge capacity is 248.8 mAh / g, and the capacity retention ratio is 92.6%.

The utility model discloses a glass medicine bottle lamp detection device belongs to medicine packing detection equipment technical field. The device includes workstation surface, and the feeding mechanism, transmission mechanism, lamp detection mechanism and the material collecting mechanism are sequentially arranged on the workstation surface. The lamp detection mechanism includes the rectangular lamp board and the magnifying glass of symmetrical layout at transmission mechanism both sides, and the center connecting line of rectangular lamp board and magnifying glass is perpendicular with the axis direction of transmission mechanism. The feeding mechanism is the feeding box of top opening, and the material collecting mechanism is the material collecting box of top opening, and transmission mechanism includes the guardrail of transmission belt and setting at both sides, and the transmission belt both ends are provided with driving wheel and driven wheel respectively, and the driving wheel axle is connected with servo motor. The start -stop switch of controlling transmission mechanism start -stop is arranged on the support below workstation. The utility model discloses through mechanization transmission and auxiliary lighting detection, has improved glass medicine bottle detection efficiency, has reduced the labor intensity of worker, has solved the problem of low efficiency of traditional manual handheld magnifying glass detection mode.

The present invention provides a glass vial for medical use, which is provided with an opening, a mouth portion, a shoulder portion, and a chamber to be filled. The glass vial is characterized in that: the vial has a thin film layer on at least a portion of the inner wall surface; the chamber to be filled has a side surface portion and a bottom surface portion; the thickness of the thin film layer in the bottom surface portion is 5-150 times thicker than the thickness of the thin film layer in the side surface portion; and the average thickness of the thin film layer in the bottom surface portion is 100-5000 nm.

The present invention relates to methods of treating Atopic Dermatitis in a human subject comprising administering a therapeutically effective amount of an anti-OX40L antibody, or antigen-binding fragment thereof, wherein the antibody or fragment thereof is administered via injection. Also provided are anti-OX40L antibodies, or antigen-binding fragments thereof, glass vials, drug delivery devices, prefilled syringes, microinfusors, pen delivery devices, autoinjectors and kits comprising an anti-OX40L antibody, or antigen-binding fragment thereof for use in such methods.

The utility model discloses glass medicine bottle stacking equipment which comprises a machine frame, a stacking chain plate mechanism is arranged on the machine frame, a bottle stacking frame and a bottle pushing frame which slide in the direction perpendicular to the conveying direction of the stacking chain plate mechanism are arranged on the machine frame and above the stacking chain plate mechanism, a sliding seat is arranged on the bottle stacking frame, and the bottle pushing frame is arranged on the sliding seat. A switching cylinder for driving the sliding seat to move is arranged on the bottle stacking frame, and a bottle separating seat and a resetting cylinder for driving the bottle separating seat to move up and down are movably arranged on the sliding seat; at least three bottle separating plates are arranged on the bottle separating seat in parallel, and a channel for accommodating a single row of glass medicine bottles is arranged between every two adjacent bottle separating plates; a middle conveying chain plate mechanism is arranged beside the stacking chain plate mechanism on the rack, the upper surface of the middle conveying chain plate mechanism is lower than the stacking chain plate mechanism, the conveying direction of the middle conveying chain plate mechanism is perpendicular to the stacking chain plate mechanism, and a lifting base and a lifting power device driving the lifting base to move are arranged on the discharging side of a middle conveying chain plate on the rack. The lifting seat is provided with a pair of tray discharging chain mechanisms which are used for stacking the trays containing the medicine bottles and then sending out the trays.